Troponin Rapid Tests and Point of Care (POC) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Troponin rapid tests & point of care (POC) are point-of-care diagnostic tests that enable to the measurement of troponin levels specific to cardiovascular diseases in a patient’s sample. The troponin rapid tests & point of care pipeline product market report provides key information and data related to extensive coverage of the troponin rapid tests & point of care under development. The report also provides details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.

Which are the key territories in the troponin rapid tests & point of care pipeline product market?

The US is the leading country in the troponin rapid tests & point of care pipeline product market with the highest number of pipeline products followed by Europe, New Zealand, Australia, and China.

Troponin rapid tests & point of care pipeline product market, by territory

Troponin rapid tests & point of care pipeline product market, by territory

For more territorial insights, download a free sample

Which are the key regulatory paths in the troponin rapid tests & point of care pipeline product market?

510(k), CE-IVD, TGA, NMPA are the key regulatory paths used in the troponin rapid tests & POC pipeline product market. 510(k) was the most popular regulatory path in the troponin rapid tests & POC pipeline product market followed by CE-IVD, TGA, and NMPA.

Troponin rapid tests & point of care pipeline product market, by regulatory path

Troponin rapid tests & point of care pipeline product market, by regulatory path

For more key regulatory phase insights, download a free sample

Which are the key companies in the troponin rapid tests & point of care pipeline product market?

The rapid tests & POC pipeline products market report offers detailed information on pipeline products of several companies including Abbott Point of Care Inc, Angle Biosciences Inc, Anteo Technologies Pty Ltd, BBB Technologies Inc, Bio-AMD Inc, Bluejay Diagnostics Inc, Carclo Diagnostic Solutions Ltd, Group K Diagnostics, LumiraDx Ltd, and MML Ltd.

Abbott Point of Care Inc: Abbott Point of Care Inc (Abbott Point), a subsidiary of Abbott Laboratories, is a medical device company that offers diagnostic products. The company manufactures, develops, and distributes medical diagnostic and data management products for in-vitro diagnostic and healthcare markets. Its products comprise of handheld blood analyzers, cardiac markers, lactate, blood gases, electrolytes, lab information systems, electronic medical recording systems, and automated clinical chemistry systems

Angle Biosciences Inc: Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors, and software products. It offers technical and application support, on-site and in-house training, extended warranty, service and maintenance contracts, and custom application development services.

Anteo Technologies Pty Ltd: Anteo Technologies Pty Ltd (Anteo) is focused on developing and commercializing high-value opportunities for the company’s core technology and has existing products in the life sciences research and in-vitro-diagnostics markets.

BBB Technologies Inc

BBB Technologies Inc (BBB Tech) is a development-stage medical technology company that develops medical devices and applications that facilitate the early diagnosis of metabolic and cardiovascular disorders. It discovers and develops single-drop and mobile integrated diagnostic tools for blood testing.

Troponin rapid tests & point of care pipeline product market, by company

Troponin rapid tests & point of care pipeline product market, by companyTo know more about key companies, download a free sample

Market report scope

Segment by stage of development  Early Development, Clinical, In Approval Process, and Inactive
Segment by territory  The US, Europe, New Zealand, Australia, and China
Segment by regulatory path  510(k), CE-IVD, TGA, and NMPA
Key companies  Abbott Point of Care Inc, Angle Biosciences Inc, Anteo Technologies Pty Ltd, BBB Technologies Inc, Bio-AMD Inc, Bluejay Diagnostics Inc, Carclo Diagnostic Solutions Ltd, Group K Diagnostics, LumiraDx Ltd, and MML Ltd

Scope

  • Extensive coverage of the troponin rapid tests & point of care under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of troponin rapid tests & point of care and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with the potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Identify and understand important and diverse types of troponin rapid tests & point of care under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Abbott Point of Care Inc
Angle Biosciences Inc
Anteo Technologies Pty Ltd
BBB Technologies Inc
Bio-AMD Inc
Bluejay Diagnostics Inc
Carclo Diagnostic Solutions Ltd
Group K Diagnostics
LumiraDx Ltd
MML Ltd
Nanomix Inc
Ohmx Corp
OPKO Health Inc
Proxim Diagnostics Corp
Resdin Technologies Inc.
Sandia National Laboratories
SpinChip Diagnostics AS

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Troponin Rapid Tests & POC Overview 8

3 Products under Development 9

3.1 Troponin Rapid Tests & POC – Pipeline Products by Stage of Development 9

3.2 Troponin Rapid Tests & POC – Pipeline Products by Territory 10

3.3 Troponin Rapid Tests & POC – Pipeline Products by Regulatory Path 11

3.4 Troponin Rapid Tests & POC – Pipeline Products by Estimated Approval Date 12

4 Troponin Rapid Tests & POC – Pipeline Products under Development by Companies 13

4.1 Troponin Rapid Tests & POC Companies – Pipeline Products by Stage of Development 13

4.2 Troponin Rapid Tests & POC – Pipeline Products by Stage of Development 14

5 Troponin Rapid Tests & POC Companies and Product Overview 15

5.1 Abbott Point of Care Inc Company Overview 15

5.1.1 Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview 15

5.2 Angle Biosciences Inc Company Overview 16

5.2.1 Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 Anteo Technologies Pty Ltd Company Overview 17

5.3.1 Anteo Technologies Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 17

5.4 BBB Technologies Inc Company Overview 18

5.4.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.5 Bio-AMD Inc Company Overview 20

5.5.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.6 Bluejay Diagnostics Inc Company Overview 21

5.6.1 Bluejay Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.7 Carclo Diagnostic Solutions Ltd Company Overview 22

5.7.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

5.8 Group K Diagnostics Company Overview 23

5.8.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 23

5.9 LumiraDx Ltd Company Overview 24

5.9.1 LumiraDx Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

5.10 MML Ltd Company Overview 25

5.10.1 MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

5.11 Nanomix Inc Company Overview 26

5.11.1 Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.12 Ohmx Corp Company Overview 27

5.12.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 27

5.13 OPKO Health Inc Company Overview 29

5.13.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.14 Proxim Diagnostics Corp Company Overview 30

5.14.1 Proxim Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 30

5.15 Resdin Technologies Inc. Company Overview 31

5.15.1 Resdin Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

5.16 Sandia National Laboratories Company Overview 32

5.16.1 Sandia National Laboratories Pipeline Products & Ongoing Clinical Trials Overview 32

5.17 SpinChip Diagnostics AS Company Overview 33

5.17.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 33

6 Troponin Rapid Tests & POC- Recent Developments 34

6.1 Sep 01, 2021: BioMerieux announce First-Half 2021 Results 34

7 Appendix 35

7.1 Methodology 35

7.2 About GlobalData 38

7.3 Contact Us 38

Table

Troponin Rapid Tests & POC – Pipeline Products by Stage of Development 9

Troponin Rapid Tests & POC – Pipeline Products by Territory 10

Troponin Rapid Tests & POC – Pipeline Products by Regulatory Path 11

Troponin Rapid Tests & POC – Pipeline Products by Estimated Approval Date 12

Troponin Rapid Tests & POC Companies – Pipeline Products by Stage of Development 13

Troponin Rapid Tests & POC – Pipeline Products by Stage of Development 14

Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview 15

i-STAT TnI-Nx – Product Status 15

i-STAT TnI-Nx – Product Description 15

Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 16

Cardiac Troponin Biomarker Kit – Product Status 16

Cardiac Troponin Biomarker Kit – Product Description 16

Anteo Technologies Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 17

AtomoRapid – Heart Attack – Product Status 17

AtomoRapid – Heart Attack – Product Description 17

BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 18

markB – cTnl Test – Product Status 18

markB – cTnl Test – Product Description 18

Mobile RDT Reader – Troponin-I Test – Product Status 19

Mobile RDT Reader – Troponin-I Test – Product Description 19

Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Magnetic Immunoassay Detection System – Cardiac Troponin – Product Status 20

Magnetic Immunoassay Detection System – Cardiac Troponin – Product Description 20

Bluejay Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Symphony hsTNT/I – Product Status 21

Symphony hsTNT/I – Product Description 21

Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

Micropoc-pro – Troponin-I Assay – Product Status 22

Micropoc-pro – Troponin-I Assay – Product Description 22

Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 23

Multidiagnostic – Troponin T And I Test – Product Status 23

Multidiagnostic – Troponin T And I Test – Product Description 23

LumiraDx Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

LumiraDx – High Sensitivity Troponin I Test – Product Status 24

LumiraDx – High Sensitivity Troponin I Test – Product Description 24

MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

MIDS Cardiac – Troponin Test – Product Status 25

MIDS Cardiac – Troponin Test – Product Description 25

Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview 26

eLab Critical Cardiac Test – Product Status 26

eLab Critical Cardiac Test – Product Description 26

Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 27

Diagnostic Assay – hs Troponin I – Product Status 27

Diagnostic Assay – hs Troponin I – Product Description 27

Portable POC System – hs Troponin I – Product Status 28

Portable POC System – hs Troponin I – Product Description 28

OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Diagnostic Assay – CTnl – Product Status 29

Diagnostic Assay – CTnl – Product Description 29

Proxim Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 30

POC Immunodiagnostic System – hs-cTnl – Product Status 30

POC Immunodiagnostic System – hs-cTnl – Product Description 30

Resdin Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

Quick At-Home Diagnostic Test – Myocardial Infarction – Product Status 31

Quick At-Home Diagnostic Test – Myocardial Infarction – Product Description 31

Sandia National Laboratories Pipeline Products & Ongoing Clinical Trials Overview 32

RapiDx Assay – cTN – Product Status 32

RapiDx Assay – cTN – Product Description 32

SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 33

cTnl Assay – Product Status 33

cTnl Assay – Product Description 33

Figures

Troponin Rapid Tests & POC – Pipeline Products by Stage of Development 9

Troponin Rapid Tests & POC – Pipeline Products by Territory 10

Troponin Rapid Tests & POC – Pipeline Products by Regulatory Path 11

Frequently asked questions

Troponin Rapid Tests and Point of Care (POC) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 thematic reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Troponin Rapid Tests and Point of Care (POC) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Troponin Rapid Tests and Point of Care (POC) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live Troponin Rapid Tests and Point of Care (POC) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.